Lamattina John L's Form 4 filing
Ligand Pharmaceuticals Inc (LGND) · filed Nov 12, 2025
- Accession no.
- 0002001011-25-000097
- Filed
- Nov 12, 2025
- Trade date
- Nov 7, 2025
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $858.6K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lamattina John LCIK 0001216074 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 7, 2025 | Common Stock | MOption exerciseAcquired | +2,145 | $66.13 | +$141,848.85 | 32,869 | Direct | |
| Nov 7, 2025 | Common Stock | SSaleDisposed | −2,145 | $205.45 | −$440,690.25 | 30,724 | Direct | |
| Nov 7, 2025 | Common Stock | MOption exerciseAcquired | +2,034 | $69.51 | +$141,383.34 | 32,758 | Direct | |
| Nov 7, 2025 | Common Stock | SSaleDisposed | −2,034 | $205.45 | −$417,885.3 | 30,724 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 7, 2025 | Common Stock | MOption exerciseDisposed | −2,145 | $0.00 | $0 | 0 | Direct | |
| Nov 7, 2025 | Common Stock | MOption exerciseDisposed | −2,034 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.